Banco Santander-Chile (NYSE: BSAC) and Banco Bilbao Vizcaya Argentaria (NYSE:BBVA) are both large-cap finance companies, but which is the superior business? We will compare the two companies based on the strength of their risk, profitability, dividends, institutional ownership, valuation, earnings and analyst recommendations.
Get Banco Santander-Chile alerts:
This is a breakdown of recent ratings and price targets for Banco Santander-Chile and Banco Bilbao Vizcaya Argentaria, as provided by MarketBeat.com.
Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Banco Santander-Chile 2 2 0 0 1.50
Banco Bilbao Vizcaya Argentaria 0 2 2 0 2.50
Banco Santander-Chile presently has a consensus target price of $29.50, indicating a potential downside of 6.68%. Banco Bilbao Vizcaya Argentaria has a consensus target price of $7.79, indicating a potential upside of 4.85%. Given Banco Bilbao Vizcaya Argentaria’s stronger consensus rating and higher possible upside, analysts clearly believe Banco Bilbao Vizcaya Argentaria is more favorable than Banco Santander-Chile.
Best Stocks For 2019: Nu Skin Enterprises Inc.(NUS)
- [By Jeremy Bowman]
Shares of Nu Skin Enterprises Inc. (NYSE:NUS) were looking attractive today after the beauty and skin-care company turned in better-than-expected results in its second-quarter earnings report. As a result, the stock was up 12.8% as of 11:56 a.m. EDT.
- [By Shane Hupp]
Pivotal Research reaffirmed their buy rating on shares of Nu Skin Enterprises (NYSE:NUS) in a research report sent to investors on Wednesday morning. They currently have a $85.00 target price on the stock.
- [By Joseph Griffin]
Vident Investment Advisory LLC acquired a new stake in Nu Skin Enterprises, Inc. (NYSE:NUS) in the second quarter, according to the company in its most recent filing with the SEC. The firm acquired 4,458 shares of the company’s stock, valued at approximately $349,000.
- [By Ethan Ryder]
Mackay Shields LLC trimmed its stake in shares of Nu Skin Enterprises, Inc. (NYSE:NUS) by 49.8% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 162,902 shares of the company’s stock after selling 161,381 shares during the quarter. Mackay Shields LLC’s holdings in Nu Skin Enterprises were worth $12,737,000 at the end of the most recent quarter.
Best Stocks For 2019: Itron Inc.(ITRI)
- [By Ethan Ryder]
Get a free copy of the Zacks research report on Itron (ITRI)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Garrett Baldwin]
Eight Seconds… $1,260 Richer: Words can’t describe what you’ll see in this shocking footage – because you’ll witness, live on camera, one man become $4,238 richer with just three clicks of a mouse. And if you follow the simple instructions in this video, you’ll learn how to set yourself up for an instant $2,918 payday opportunity. You need to see this to believe it…
Three Stocks to Watch Today: COP, HD, HSBC
ConocoPhillips (NYSE: COP) has seized assets from the Venezuelan-owned firm PDVSA in the Caribbean. The company won a court case that will allow it to take over assets owned by the Venezuelan government. The court enabled the seizures as part of a broader plan to allow the firm to recoup roughly $2 billion following the 2007 nationalization of its assets in Venezuela by the huge Castro-led government.
Monday will be a quiet day on the earnings front. Investors are looking to Tuesday’s calendar, when The Home Depot Inc. (NYSE: HD) reports earnings. Tomorrow, Wall Street analysts expect that Home Depot will report earnings per share of $2.07 on top of $25.2 billion in revenue. Investors will be hoping that the company reports strong profits thanks to an improving U.S. economy and the recent tax reform law.
Expect a lot of chatter today about blockchain technology. That’s because ING Bank and HSBC Holdings Plc. (NYSE: HSBC) announced over the weekend that they engaged in their first trade ever using blockchain technology. The two engaged in a trade on behalf of Cargill to finance a shipment of soybeans from Argentina to Malaysia.
Today, look for earnings reports from Agilent Technologies (NYSE: A), Itron Inc. (Nasdaq: ITRI), Vipshop Holdings Ltd. (Nasdaq: VIPS), Amyris Biotechnologies Inc. (Nasdaq: AMRS), Sky Solar Holdings Ltd. (Nasdaq: SKYS), Mazor Robotics Ltd. (Nasdaq: MZOR), China Lodging Group Ltd. (Nasdaq: HTHT), and Mimecast Ltd. (Nasdaq: MIME).
Follow Money Morning on Facebook, Twitter, and LinkedIn.
- [By Stephan Byrd]
Itron (NASDAQ:ITRI) major shareholder Scopia Capital Management Lp purchased 114,129 shares of the company’s stock in a transaction dated Monday, May 21st. The stock was purchased at an average price of $59.34 per share, for a total transaction of $6,772,414.86. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Major shareholders that own more than 10% of a company’s stock are required to disclose their transactions with the SEC.
- [By Logan Wallace]
TheStreet cut shares of Itron (NASDAQ:ITRI) from a b rating to a c rating in a research note issued to investors on Monday morning.
Several other equities analysts also recently weighed in on ITRI. BidaskClub upgraded Itron from a hold rating to a buy rating in a research report on Friday, January 19th. Oppenheimer reiterated a buy rating and set a $78.00 price objective on shares of Itron in a research report on Monday, January 29th. Canaccord Genuity upgraded Itron from a hold rating to a buy rating and lifted their price objective for the stock from $78.00 to $84.00 in a research report on Tuesday, February 27th. Cowen upgraded Itron from a market perform rating to an outperform rating and lifted their price objective for the stock from $80.00 to $84.00 in a research report on Thursday, March 1st. Finally, JMP Securities set a $108.00 price objective on Itron and gave the stock a buy rating in a research report on Thursday, March 1st. Six equities research analysts have rated the stock with a hold rating, six have assigned a buy rating and two have issued a strong buy rating to the company’s stock. The company currently has a consensus rating of Buy and a consensus price target of $83.36.
Best Stocks For 2019: Adams Diversified Equity Fund, Inc.(ADX)
- [By Stephan Byrd]
AdEx (CURRENCY:ADX) traded 3.5% higher against the U.S. dollar during the twenty-four hour period ending at 18:00 PM Eastern on September 3rd. One AdEx token can currently be bought for $0.22 or 0.00003064 BTC on popular cryptocurrency exchanges including EtherDelta (ForkDelta), Bittrex, IDEX and Upbit. AdEx has a total market cap of $16.37 million and $1.48 million worth of AdEx was traded on exchanges in the last day. Over the last seven days, AdEx has traded 12% higher against the U.S. dollar.
- [By Max Byerly]
AdEx (CURRENCY:ADX) traded up 9.2% against the dollar during the twenty-four hour period ending at 18:00 PM Eastern on April 24th. In the last seven days, AdEx has traded up 47.7% against the dollar. One AdEx token can now be purchased for about $1.12 or 0.00011782 BTC on major cryptocurrency exchanges including IDEX, Huobi, EtherDelta (ForkDelta) and Liqui. AdEx has a total market cap of $81.99 million and approximately $13.84 million worth of AdEx was traded on exchanges in the last day.
- [By Shane Hupp]
AdEx (CURRENCY:ADX) traded 2.3% lower against the U.S. dollar during the 1-day period ending at 15:00 PM E.T. on May 12th. One AdEx token can now be purchased for $0.77 or 0.00009068 BTC on major cryptocurrency exchanges including IDEX, EtherDelta (ForkDelta), Binance and Gatecoin. During the last seven days, AdEx has traded 25.9% lower against the U.S. dollar. AdEx has a total market cap of $56.24 million and $2.87 million worth of AdEx was traded on exchanges in the last day.